Research Nester released a report titled “Hemoperfusion Production Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global hemoperfusion production market in terms of market segmentation by adsorption, by application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The market for hemoperfusion production is anticipated to grow at a significant CAGR during the forecast period, i.e. 2019-2027. The market is segmented by adsorption, by application and by region, out of which, the adsorption segment is further bifurcated into charcoal hemoperfusion and resin hemoperfusion. On the basis of adsorption, the charcoal hemoperfusion segment is estimated to hold the largest segment on account of growing usage of activated charcoal columns as activated charcoal has a high affinity for water soluble molecules. The resin hemoperfusion column has a high affinity for lipid soluble molecules, however, the low availability of resin columns for hemoperfusion is estimated to restrict the growth of this segment in the market.
The market in North America is estimated to hold the largest share in the hemoperfusion production market on account of rising healthcare expenditure and the growing presence of key market players in the region, especially in the United States. On the other hand, the highest growth is estimated to be observed by the market in Asia-Pacific region as a result of rapidly growing healthcare infrastructure in the region. Moreover, the rising awareness about the various treatment methods available among the population in this region is anticipated to further result in growth for the market.
Rising Blood-Related Disorders to Support the Market Growth
According to WHO, Sepsis was estimated to affect more than 30 million people globally every year, potentially resulting in 6 million deaths, mainly in low and middle-income countries. The growing incidences of sepsis and other such conditions is estimated to raise the demand for hemoperfusion treatment techniques, thereby leading to significant market growth. However, the various risks associated with hemoperfusion technique such as blood infection, clotting of blood, damage to blood platelets and decrease in blood pressure are anticipated to hamper the market growth during the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global hemoperfusion production market which includes company profiling of Baxter (Gambro) (BAX), Toray Medical, Asahi-Kasei, Spectral Medical Inc., Kaneka Pharma, Jafron Biomedical, Biosun Medical, Zibo Kangbei, Cytosorbents (CTSO) and Kangbei Medical Device. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global hemoperfusion production market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
